Evaluating the controlled release properties of inhaled nanoparticles using isolated, perfused, and ventilated lung models

Journal of Nanomaterials

Volumn 2011, Issue , 2011, Pages

  Gessler, Tobias ^a   Beck Broichsitter, Moritz ^a   Schmehl, Thomas ^a   Seeger, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED DRUG RELEASE; CONTROLLED RELEASE PROPERTIES; CONVENTIONAL ANALYTICAL; DRUG DELIVERY SYSTEM; DRUG RELEASE; EX-VIVO; IN-VITRO TESTS; IN-VIVO; INHALATION THERAPY; LUNG MODEL; PHYSICOCHEMICAL PROPERTY; POLYMERIC MATERIAL; POLYMERIC NANOPARTICLES; PREPARATION TECHNIQUE; PULMONARY DELIVERY; RELEASE PROPERTY; SPECIFIC EFFECTS;

BIOLOGICAL ORGANS; DRUG THERAPY; NANOPARTICLES; POLYMERS; RESPIRATORY THERAPY;

CONTROLLED DRUG DELIVERY;

EID: 79952160334     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2011/163791     Document Type: Review

References (177)

1. Taylor G., Kellaway I., Hillery A., Lloyd A. W., Swabrick J., Pulmonary drug delivery Drug Delivery and Targeting 2001 London, UK Routledge Chapman Hall 269 300
2. Bisgaard H., O'Callaghan C., Smaldone G. C., Drug Delivery to the Lung 2002 New York, NY, USA Informa Healthcare
3. Courrier H. M., Butz N., Vandamme TH. F., Pulmonary drug delivery systems: recent developments and prospects Critical Reviews (Pubitemid 36314479)
4. Groneberg D. A., Witt C., Wagner U., Chung K. F., Fischer A., Fundamentals of pulmonary drug delivery Respiratory Medicine 2003 97 4 382 387 (Pubitemid 36410606)
5. Gessler T., Seeger W., Schmehl T., Inhaled prostanoids in the therapy of pulmonary hypertension Journal of Aerosol Medicine 2008 21 1 1 12
6. Mobley C., Hochhaus G., Methods used to assess pulmonary deposition and absorption of drugs Drug Discovery Today 2001 6 7 367 375 (Pubitemid 32208651)
7. Labiris N. R., Dolovich M. B., Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications British Journal of Clinical Pharmacology 2003 56 6 588 599 (Pubitemid 37491710)
8. Labiris N. R., Dolovich M. B., Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications British Journal of Clinical Pharmacology 2003 56 6 600 612 (Pubitemid 37491711)
9. Zeng X. M., Martin G. P., Marriott C., The controlled delivery of drugs to the lung International Journal of Pharmaceutics 1995 124 2 149 164
10. Hardy J. G., Chadwick T. S., Sustained release drug delivery to the lungs. An option for the future Clinical Pharmacokinetics 2000 39 1 1 4 (Pubitemid 30468201)
11. Xie Y., Zeng P., Wiedmann T. S., Disease guided optimization of the respiratory delivery of microparticulate formulations Expert Opinion on Drug Delivery 2008 5 3 269 289 (Pubitemid 351454378)
12. Langer R., New methods of drug delivery Science 1990 249 4976 1527 1533
13. Langer R., Drug delivery and targeting Nature 1998 392 6679, supplement 5 10 (Pubitemid 28215187)
14. La Van D. A., Lynn D. M., Langer R., Moving smaller in drug discovery and delivery Nature Reviews Drug Discovery 2002 1 1 77 84 (Pubitemid 37361406)
15. Farokhzad O. C., Langer R., Impact of nanotechnology on drug delivery ACS Nano 2009 3 1 16 20
16. Mishra B., Patel B. B., Tiwari S., Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery Nanomedicine 2010 6 1 e9 e24
17. Soppimath K. S., Aminabhavi T. M., Kulkarni A. R., Rudzinski W. E., Biodegradable polymeric nanoparticles as drug delivery devices Journal of Controlled Release 2001 70 1-2 1 20 (Pubitemid 32144788)
18. Panyam J., Labhasetwar V., Biodegradable nanoparticles for drug and gene delivery to cells and tissue Advanced Drug Delivery Reviews 2003 55 3 329 347 (Pubitemid 36297053)
19. Koo O. M., Rubinstein I., Onyuksel H., Role of nanotechnology in targeted drug delivery and imaging: a concise review Nanomedicine 2005 1 3 193 212 (Pubitemid 43963632)
20. Rogueda P. G. A., Traini D., The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects Expert Opinion on Drug Delivery 2007 4 6 595 606 (Pubitemid 350193398)
21. Rogueda P. G. A., Traini D., The nanoscale in pulmonary delivery. Part 2: formulation platforms Expert Opinion on Drug Delivery 2007 4 6 607 620 (Pubitemid 350199199)
22. Azarmi S., Roa W. H., Lbenberg R., Targeted delivery of nanoparticles for the treatment of lung diseases Advanced Drug Delivery Reviews 2008 60 8 863 875
23. Rytting E., Nguyen J., Wang X., Kissel T., Biodegradable polymeric nanocarriers for pulmonary drug delivery Expert Opinion on Drug Delivery 2008 5 6 629 639 (Pubitemid 351998253)
24. Lebhardt T., Roesler S., Beck-Broichsitter M., Kissel T., Polymeric nanocarriers for drug delivery to the lung Journal of Drug Delivery Science and Technology 2010 20 3 171 180
25. Vauthier C., Bouchemal K., Methods for the preparation and manufacture of polymeric nanoparticles Pharmaceutical Research 2009 26 5 1025 1058
26. Mora-Huertas C. E., Fessi H., Elaissari A., Polymer-based nanocapsules for drug delivery International Journal of Pharmaceutics 2010 385 1-2 113 142
27. Anderson J. M., Shive M. S., Biodegradation and biocompatibility of PLA and PLGA microspheres Advanced Drug Delivery Reviews 1997 28 1 5 24 (Pubitemid 27497671)
28. Bala I., Hariharan S., Kumar M. N. V. R., PLGA nanoparticles in drug delivery: the state of the art Critical Reviews in Therapeutic Drug Carrier Systems 2004 21 5 387 422 (Pubitemid 41647578)
29. Astete C. E., Sabliov C. M., Synthesis and characterization of PLGA nanoparticles Journal of Biomaterials Science, Polymer Edition 2006 17 3 247 289 (Pubitemid 47279194)
30. Washington C., Drug release from microdisperse systems: a critical review International Journal of Pharmaceutics 1990 58 1 1 12 (Pubitemid 20034221)
31. Kreuter J., Colloidal Drug Delivery Systems 1994 New York, NY, USA Marcel Dekker
32. Sakagami M., In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery Advanced Drug Delivery Reviews 2006 58 9-10 1030 1060 (Pubitemid 44712023)
33. Tronde A., Bosquillon C., Forbes B., Erhardt C., Kim K. J., The isolated perfused lung for drug absorption studies Biotechnology Pharmaceutical Aspects VII 2008 7 Berlin, Germany Springer 135 163 Drug Absorption Studies
34. Fernandes C. A., Vanbever R., Preclinical models for pulmonary drug delivery Expert opinion on drug delivery 2009 6 11 1231 1245
35. Kreuter J., Nanoparticles-a historical perspective International Journal of Pharmaceutics 2007 331 1 1 10 (Pubitemid 46176507)
36. Peer D., Karp J. M., Hong S., Farokhzad O. C., Margalit R., Langer R., Nanocarriers as an emerging platform for cancer therapy Nature Nanotechnology 2007 2 12 751 760 (Pubitemid 350223348)
37. Hawkins M. J., Soon-Shiong P., Desai N., Protein nanoparticles as drug carriers in clinical medicine Advanced Drug Delivery Reviews 2008 60 8 876 885
38. Bur M., Henning A., Hein S., Schneider M., Lehr C. M., Inhalative nanomedicine-opportunities and challenges Inhalation Toxicology 2009 21 supplement 1 137 143
39. Roy I., Vij N., Nanodelivery in airway diseases: challenges and therapeutic applications Nanomedicine 2010 6 2 237 244
40. Dhand R., Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol Respiratory Care 2002 47 12 1406 1416
41. Waldrep J. C., Dhand R., Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation Current Drug Delivery 2008 5 2 114 119 (Pubitemid 351536317)
42. Dailey L. A., Schmehl T., Gessler T., Wittmar M., Grimminger F., Seeger W., Kissel T., Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features Journal of Controlled Release 2003 86 1 131 144 (Pubitemid 35461980)
43. Hinds W. C., Aerosol Technology: Properties, Behavior, and Measurements of Airborne Particles 1999 New York, NY, USA John Wiley Sons
44. Crapo J. D., Barry B. E., Gehr P., Bachofen M., Weibel E. R., Cell number and cell characteristics of the normal human lung American Review of Respiratory Disease 1982 126 2 332 337 (Pubitemid 12047098)
45. Forbes B., Ehrhardt C., Human respiratory epithelial cell culture for drug delivery applications European Journal of Pharmaceutics and Biopharmaceutics 2005 60 2 193 205 (Pubitemid 40804561)
46. Weibel E. R., Morphometry of the Human Lung 1963 Berlin, Germany Springer
47. Evans C. M., Koo JA. S., Airway mucus: the good, the bad, the sticky Pharmacology and Therapeutics 2009 121 3 332 348
48. Marriott C., Mucus and mucociliary clearance in the respiratory tract Advanced Drug Delivery Reviews 1990 5 1-2 19 35 (Pubitemid 20333014)
49. Lansley A. B., Mucociliary clearance and drug delivery via the respiratory tract Advanced Drug Delivery Reviews 1993 11 3 299 327 (Pubitemid 23302850)
50. Creuwels L. A. J. M., Van Golde L. M. G., Haagsman H. P., The pulmonary surfactant system: biochemical and clinical aspects Lung 1997 175 1 1 39 (Pubitemid 26412518)
51. Goerke J., Pulmonary surfactant: functions and molecular composition Biochimica et Biophysica Acta 1998 1408 2-3 79 89 (Pubitemid 28517859)
52. Veldhuizen R., Nag K., Orgeig S., Possmayer F., The role of lipids in pulmonary surfactant Biochimica et Biophysica Acta 1998 1408 2-3 90 108 (Pubitemid 28517860)
53. Prez-Gil J., Keough K. M. W., Interfacial properties of surfactant proteins Biochimica et Biophysica Acta 1998 1408 2-3 203 217 (Pubitemid 28517867)
54. Wstneck R., Perez-Gil J., Wstneck N., Cruz A., Fainerman V. B., Pison U., Interfacial properties of pulmonary surfactant layers Advances in Colloid and Interface Science 2005 117 1-3 33 58 (Pubitemid 41679426)
55. Prez-Gil J., Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions Biochimica et Biophysica Acta 2008 1778 7-8 1676 1695
56. Fehrenbach H., Alveolar epithelial type II cell: defender of the alveolus revisited Respiratory Research 2001 2 1 33 46 (Pubitemid 34187905)
57. Ehrhardt M., Laue M., Kim K. J., Erhardt C., Kim K. J., In vitro models of the alveolar epithelial barrier Biotechnology Pharmaceutical Aspects VII 2008 Berlin, Germany Springer 258 282 Drug Absorption Studies
58. Patton J. S., Mechanisms of macromolecule absorption by the lungs Advanced Drug Delivery Reviews 1996 19 1 3 36 (Pubitemid 26167852)
59. Gumbleton M., Caveolae as potential macromolecule trafficking compartments within alveolar epithelium Advanced Drug Delivery Reviews 2001 49 3 281 300 (Pubitemid 32718689)
60. Brain J. D., Mechanisms, measurement, and significance of lung macrophage function Environmental Health Perspectives 1992 97 5 10
61. Palecanda A., Kobzik L., Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors Current Molecular Medicine 2001 1 5 589 595 (Pubitemid 33772037)
62. Yu J., Chien Y. W., Pulmonary drug delivery: physiologic and mechanistic aspects Critical Reviews in Therapeutic Drug Carrier Systems 1997 14 4 395 453 (Pubitemid 28036074)
63. Pison U., Welte T., Giersig M., Groneberg D. A., Nanomedicine for respiratory diseases European Journal of Pharmacology 2006 533 13 341 350 (Pubitemid 43340025)
64. Sung J. C., Pulliam B. L., Edwards D. A., Nanoparticles for drug delivery to the lungs Trends in Biotechnology 2007 25 12 563 570 (Pubitemid 350138179)
65. Smola M., Vandamme T., Sokolowski A., Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases International Journal of Nanomedicine 2008 3 1 1 19 (Pubitemid 351517072)
66. Yang W., Peters J. I., Williams R. O., Inhaled nanoparticles. A current review International Journal of Pharmaceutics 2008 356 1-2 239 247
67. Bailey M. M., Berkland C. J., Nanoparticle formulations in pulmonary drug delivery Medicinal Research Reviews 2009 29 1 196 212
68. Mansour H. M., Rhee Y. S., Wu X., Nanomedicine in pulmonary delivery International journal of nanomedicine 2009 4 299 319
69. Oberdrster G., Oberdrster E., Oberdrster J., Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environmental Health Perspectives 2005 113 7 823 839
70. Cartiera M. S., Johnson K. M., Rajendran V., Caplan M. J., Saltzman W. M., The uptake and intracellular fate of PLGA nanoparticles in epithelial cells Biomaterials 2009 30 14 2790 2798
71. Patton J. S., Platz R. M., Pulmonary delivery of peptides and proteins for systemic action Advanced Drug Delivery Reviews 1992 8 2-3 179 196
72. Byron P. R., Patton J. S., Drug delivery via the respiratory tract Journal of Aerosol Medicine 1994 7 1 49 75 (Pubitemid 24277024)
73. Niven R. W., Delivery of biotherapeutics by inhalation aerosol Critical Reviews in Therapeutic Drug Carrier Systems 1995 12 2-3 151 231
74. Agu R. U., Ugwoke M. I., Armand M., Kinget R., Verbeke N., The lung as a route for systemic delivery of therapeutic proteins and peptides Respiratory Research 2001 2 4 198 209 (Pubitemid 34187927)
75. Scheuch G., Kohlhaeufl M. J., Brand P., Siekmeier R., Clinical perspectives on pulmonary systemic and macromolecular delivery Advanced Drug Delivery Reviews 2006 58 9-10 996 1008 (Pubitemid 44709266)
76. Patton J. S., Byron P. R., Inhaling medicines: delivering drugs to the body through the lungs Nature Reviews Drug Discovery 2007 6 1 67 74 (Pubitemid 46020287)
77. Siekmeier R., Scheuch G., Systemic treatment by inhalation of macromoleculesprinciples, problems, and examples Journal of Physiology and Pharmacology 2008 59 6 53 79
78. Bailey C., Barnett A., Why is Exubera being withdrawn? British Medical Journal 2007 335 7630 1156
79. Kling J., Inhaled insulin's last gasp? Nature Biotechnology 2008 26 5 479 480 (Pubitemid 351668021)
80. Volsko T., Reed M. D., Drugs used in the treatment of asthma: a review of clinical pharmacology and aerosol drug delivery Respiratory care clinics of North America 2000 6 1 41 55
81. Sin D. D., Paul Man S. F., Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease Drugs and Aging 2003 20 12 867 880 (Pubitemid 37340279)
82. Gessler T., Schmehl T., Olschewski H., Grimminger F., Seeger W., Aerosolized vasodilators in pulmonary hypertension Journal of Aerosol Medicine 2002 15 2 117 122 (Pubitemid 34827524)
83. Olschewski H., Simonneau G., Gali N., Higenbottam T., Naeije R., Rubin L. J., Nikkho S., Speich R., Hoeper M. M., Behr J., Winkler J., Sitbon O., Popov W., Ardeschir Ghofrani H., Manes A., Kiely D. G., Ewert R., Meyer A., Corris P. A., Delcroix M., Gomez-Sanchez M., Siedentop H., Seeger W., Inhaled iloprost for severe pulmonary hypertension New England Journal of Medicine 2002 347 5 322 329 (Pubitemid 34815354)
84. Clark A. R., Medical aerosol inhalers: past, present, and future Aerosol Science and Technology 1995 22 4 374 391
85. Gonda I., The ascent of pulmonary drug delivery Journal of Pharmaceutical Sciences 2000 89 7 940 945
86. Anderson P. J., History of aerosol therapy: liquid nebulization to MDIs to DPIs Respiratory Care 2005 50 9 1139 1150
87. Geller D. E., Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler Respiratory Care 2005 50 10 1313 1321 (Pubitemid 46173315)
88. Newman S. P., Principles of metered-dose inhaler design Respiratory Care 2005 50 9 1177 1190
89. Atkins P. J., Dry powder inhalers: an overview Respiratory Care 2005 50 10 1304 1312 (Pubitemid 46173313)
90. Fink J. B., Metered-dose inhalers, dry powder inhalers, and transitions Respiratory Care 2000 45 6 623 635 (Pubitemid 30484802)
91. Le Brun P. P. H., De Boer A. H., Frijlink H. W., Heijerman H. G. M., A review of the technical aspects of drug nebulization Pharmacy World and Science 2000 22 3 75 81
92. McCallion O. N. M., Taylor K. M. G., Bridges P. A., Thomas M., Taylor A. J., Jet nebulisers for pulmonary drug delivery International Journal of Pharmaceutics 1996 130 1 1 11 (Pubitemid 26129782)
93. Taylor K. M. G., McCallion O. N. M., Ultrasonic nebulisers for pulmonary drug delivery International Journal of Pharmaceutics 1997 153 1 93 104 (Pubitemid 27283337)
94. Knoch M., Keller M., The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems Expert Opinion on Drug Delivery 2005 2 2 377 390 (Pubitemid 41130890)
95. Gill S., Lbenberg R., Ku T., Azarmi S., Roa W., Prenner E. J., Nanoparticles: characteristics, mechanisms of action, and toxicity in pulmonary drug deliverya review Journal of Biomedical Nanotechnology 2007 3 2 107 119 (Pubitemid 351877160)
96. Card J. W., Zeldin D. C., Bonner J. C., Nestmann E. R., Pulmonary applications and toxicity of engineered nanoparticles American Journal of Physiology 2008 295 3 L400 L411
97. De Jong W. H., Borm P. J. A., Drug delivery and nanoparticles: applications and hazards International Journal of Nanomedicine 2008 3 2 133 149 (Pubitemid 352042401)
98. Vega-Villa K. R., Takemoto J. K., Yez J. A., Remsberg C. M., Forrest M. L., Davies N. M., Clinical toxicities of nanocarrier systems Advanced Drug Delivery Reviews 2008 60 8 929 938
99. Caldorera-Moore M., Peppas N. A., Micro- and nanotechnologies for intelligent and responsive biomaterial-based medical systems Advanced Drug Delivery Reviews 2009 61 15 1391 1401
100. Dailey L. A., Kissel T., New poly(lactic-co-glycolic acid) derivatives: modular polymers with tailored properties Drug Discovery Today: Technologies 2005 2 1 7 13 (Pubitemid 40946302)
101. Dailey L. A., Wittmar M., Kissel T., The role of branched polyesters and their modifications in the development of modern drug delivery vehicles Journal of Controlled Release 2005 101 13 137 149 (Pubitemid 39600978)
102. Unger F., Wittmar M., Morell F., Kissel T., Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(d,l-lactide-co-glycolide): effects of polymer structure on in vitro degradation behaviour Biomaterials 2008 29 13 2007 2014
103. Unger F., Wittmar M., Kissel T., Branched polyesters based on poly[vinyl-3-(dialkylamino)alkylcarbamate-co-vinyl acetate-co-vinyl alcohol]-graft-poly(d,l-lactide-co-glycolide): effects of polymer structure on cytotoxicity Biomaterials 2007 28 9 1610 1619 (Pubitemid 46080471)
104. Dailey L. A., Jekel N., Fink L., Gessler T., Schmehl T., Wittmar M., Kissel T., Seeger W., Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung Toxicology and Applied Pharmacology 2006 215 1 100 108 (Pubitemid 44118400)
105. Dailey L. A., Kleemann E., Wittmar M., Gessler T., Schmehl T., Roberts C., Seeger W., Kissel T., Surfactant-free, biodegradable nanoparticles for aerosol therapy based on the branched polyesters, DEAPA-PVAL-g-PLGA Pharmaceutical Research 2003 20 12 2011 2020 (Pubitemid 38005534)
106. Beck-Broichsitter M., Gauss J., Packhaeuser C. B., Lahnstein K., Schmehl T., Seeger W., Kissel T., Gessler T., Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model International Journal of Pharmaceutics 2009 367 1-2 169 178
107. Fu J., Fiegel J., Krauland E., Hanes J., New polymeric carriers for controlled drug delivery following inhalation or injection Biomaterials 2002 23 22 4425 4433
108. Fu J., Fiegel J., Hanes J., Synthesis and characterization of PEG-based ether-anhydride terpolymers: novel polymers for controlled drug delivery Macromolecules 2004 37 19 7174 7180
109. Fiegel J., Fu J., Hanes J., Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs Journal of Controlled Release 2004 96 3 411 423 (Pubitemid 38553920)
110. Barichello J. M., Morishita M., Takayama K., Nagai T., Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Development and Industrial Pharmacy 1999 25 4 471 476 (Pubitemid 29159426)
111. Govender T., Stolnik S., Garnett M. C., Illum L., Davis S. S., PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug Journal of Controlled Release 1999 57 2 171 185 (Pubitemid 29062869)
112. Wittmar M., Unger F., Kissel T., Biodegradable brushlike branched polyesters containing a charge-modified poly (vinyl alcohol) backbone as a platform for drug delivery systems: synthesis and characterization Macromolecules 2006 39 4 1417 1424
113. Wang X., Xie X., Cai C., Rytting E., Steele T., Kissel T., Biodegradable branched polyesters poly(vinyl sulfonate-covinyl alcohol)-graft poly(D,L-lactic-coglycolic acid) as a negatively charged polyelectrolyte platform for drug delivery: synthesis and characterization Macromolecules 2008 41 8 2791 2799 (Pubitemid 351685039)
114. Heyder J., Gebhart J., Rudolf G., Schiller C. F., Stahlhofen W., Deposition of particles in the human respiratory tract in the size range 0.00515 m Journal of Aerosol Science 1986 17 5 811 825 (Pubitemid 17492310)
115. Jaafar-Maalej C., Andrieu V., Elaissari A., Fessi H., Assessment methods of inhaled aerosols: technical aspects and applications Expert Opinion on Drug Delivery 2009 6 9 941 959
116. Liu J., Gong T., Fu H., Wang C., Wang X., Chen Q., Zhang Q., He Q., Zhang Z., Solid lipid nanoparticles for pulmonary delivery of insulin International Journal of Pharmaceutics 2008 356 1-2 333 344
117. Hureaux J., Lagarce F., Gagnadoux F., Vecellio L., Clavreul A., Roger E., Kempf M., Racineux J. L., Diot P., Benoit J. P., Urban T., Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel European Journal of Pharmaceutics and Biopharmaceutics 2009 73 2 239 246
118. Ghazanfari T., Elhissi A. M. A., Ding Z., Taylor K. M. G., The influence of fluid physicochemical properties on vibrating-mesh nebulization International Journal of Pharmaceutics 2007 339 1-2 103 111 (Pubitemid 46977598)
119. Chow A. H. L., Tong H. H. Y., Chattopadhyay P., Shekunov B. Y., Particle engineering for pulmonary drug delivery Pharmaceutical Research 2007 24 3 411 437 (Pubitemid 46295160)
120. Seville P. C., Li H. Y., Learoyd T. P., Spray-dried powders for pulmonary drug delivery Critical Reviews in Therapeutic Drug Carrier Systems 2007 24 4 307 360
121. Lemoine D., Francois C., Kedzierewicz F., Preat V., Hoffman M., Maincent P., Stability study of nanoparticles of poly( -caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) Biomaterials 1996 17 22 2191 2197 (Pubitemid 26364773)
122. Muthu M. S., Feng SI. S., Pharmaceutical stability aspects of nanomedicines Nanomedicine 2009 4 8 857 860
123. Abdelwahed W., Degobert G., Stainmesse S., Fessi H., Freeze-drying of nanoparticles: formulation, process and storage considerations Advanced Drug Delivery Reviews 2006 58 15 1688 1713 (Pubitemid 44827432)
124. Tewa-Tagne P., Brianon S., Fessi H., Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation European Journal of Pharmaceutical Sciences 2007 30 2 124 135 (Pubitemid 46157175)
125. Pilcer G., Amighi K., Formulation strategy and use of excipients in pulmonary drug delivery International Journal of Pharmaceutics 2010 392 1-2 1 19
126. Tomoda K., Ohkoshi T., Hirota K., Sonavane G. S., Nakajima T., Terada H., Komuro M., Kitazato K., Makino K., Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer Colloids and Surfaces B 2009 71 2 177 182
127. Sung J. C., Padilla D. J., Garcia-Contreras L., Verberkmoes J. L., Durbin D., Peloquin C. A., Elbert K. J., Hickey A. J., Edwards D. A., Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery Pharmaceutical Research 2009 26 8 1847 1855
128. Ely L., Roa W., Finlay W. H., Lbenberg R., Effervescent dry powder for respiratory drug delivery European Journal of Pharmaceutics and Biopharmaceutics 2007 65 3 346 353
129. Shi L., Plumley C. J., Berkland C., Biodegradable nanoparticle flocculates for dry powder aerosol formulation Langmuir 2007 23 22 10897 10901 (Pubitemid 350069300)
130. Peek L. J., Roberts L., Berkland C., Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins Langmuir 2008 24 17 9775 9783
131. Mathias N. R., Yamashita F., Lee V. H. L., Respiratory epithelial cell culture models for evaluation of ion and drug transport Advanced Drug Delivery Reviews 1996 22 1-2 215 249 (Pubitemid 26423603)
132. Steimer A., Haltner E., Lehr C. M., Cell culture models of the respiratory tract relevant to pulmonary drug delivery Journal of Aerosol Medicine 2005 18 2 137 182 (Pubitemid 40911357)
133. Sporty J. L., Horlkov L., Ehrhardt C., In vitro cell culture models for the assessment of pulmonary drug disposition Expert Opinion on Drug Metabolism and Toxicology 2008 4 4 333 345 (Pubitemid 351728510)
134. Amidon G. L., Lennernas H., Shah V. P., Crison J. R., A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharmaceutical Research 1995 12 3 413 420
135. Eixarch H., Haltner-Ukomadu E., Beisswenger C., Bock U., Drug delivery to the lung: permeability and physicochemical characteristics of drugs as the basis for a pulmonary biopharmaceutical classification system (pBCS) Journal of Epithelial Biology and Pharmacology 2010 3 1 14
136. Cryan S. A., Sivadas N., Garcia-Contreras L., In vivo animal models for drug delivery across the lung mucosal barrier Advanced Drug Delivery Reviews 2007 59 11 1133 1151 (Pubitemid 47628783)
137. Gerde P., Animal models and their limitations: on the problem of high-to-low dose extrapolations following inhalation exposures Experimental and Toxicologic Pathology 2005 57 1, supplement 143 146 (Pubitemid 40884486)
138. Niemeier R. W., Isolated perfused rabbit lung: a critical appraisal Environmental Health Perspectives 1976 16 67 71 (Pubitemid 8037530)
139. Mehendale H. M., Angevine L. S., Ohmiya Y., The isolated perfused lung. A critical evaluation Toxicology 1981 21 1 1 36 (Pubitemid 11087330)
140. Niemeier R. W., The isolated perfused lung Environmental Health Perspectives 1984 56 35 41 (Pubitemid 14070477)
141. Seeger W., Walmrath D., Grimminger F., Rosseau S., Schutte H., Kramer-H. J., Ermert L., Kiss L., Adult respiratory distress syndrome: model systems using isolated perfused rabbit lungs Methods in Enzymology 1994 233 549 584
142. Byron P. R., Niven R. W., A novel dosing method for drug administration to the airways of the isolated perfused rat lung Journal of Pharmaceutical Sciences 1988 77 8 693 695 (Pubitemid 19030293)
143. Byron P. R., Roberts N. S. R., Clark A. R., An isolated perfused rat lung preparation for the study of aerosolized drug deposition and absorption Journal of Pharmaceutical Sciences 1986 75 2 168 171 (Pubitemid 16162541)
144. Niven R. W., Byron P. R., Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract Pharmaceutical Research 1988 5 9 574 579
145. Niven R. W., Byron P. R., Solute absorption from the airways of the isolated rat lung II. Eeffect of surfaccants on absorption of fluorescein Pharmaceutical Research 1990 7 1 8 13 (Pubitemid 20115791)
146. Niven R. W., Rypacek F., Byron P. R., Solute absorption from the airways of the isolated rat lung. III. Absorption of several peptidase-resistant, synthetic polypeptides: poly-(2-hydroxyethyl)-aspartamides Pharmaceutical Research 1990 7 10 990 994 (Pubitemid 20366724)
147. Byron P. R., Sun Z., Katayama H., Rypacek F., Solute absorption from the airways of the isolated rat lung. IV. mechanisms of absorption of fluorophore-labeled poly-, -[N(2-hydroxyethyl)-DL-aspartamide] Pharmaceutical Research 1994 11 2 221 225 (Pubitemid 24076215)
148. Sun J. Z., Byron P. R., Rypacek F., Solute absorption from the airways of the isolated rat lung. V. Charge effects on the absorption of copolymers of N(2-hydroxyethyl)-DL-aspartamide with DL-aspartic acid or dimethylaminopropyl- DL-aspartamide Pharmaceutical Research 1999 16 7 1104 1108 (Pubitemid 29368160)
149. Sakagami M., Byron P. R., Venitz J., Rypacek F., Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalator Journal of Pharmaceutical Sciences 2002 91 2 594 604 (Pubitemid 34137376)
150. Sakagami M., Byron P. R., Rypacek F., Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lung: effects of temperature and metabolic inhibitors Journal of Pharmaceutical Sciences 2002 91 9 1958 1968 (Pubitemid 36254932)
151. Pang Y., Sakagami M., Byron P. R., The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition European Journal of Pharmaceutical Sciences 2005 25 4-5 369 378 (Pubitemid 40853864)
152. Pang Y., Sakagami M., Byron P. R., Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL) Pharmaceutical Research 2007 24 9 1636 1644 (Pubitemid 47206614)
153. Ryrfeldt A., Persson G., Nilsson E., Pulmonary disposition of the potent glucocorticoid budesonide, evaluated in an isolated perfused rat lung model Biochemical Pharmacology 1989 38 1 17 22 (Pubitemid 19029148)
154. Jess Valle M. J., Gonzlez Lpez F., Snchez Navarro A., Pulmonary versus systemic delivery of levofloxacin. The isolated lung of the rat as experimental approach for assessing pulmonary inhalation Pulmonary Pharmacology and Therapeutics 2008 21 2 298 303
155. Ewing P., Eirefelt S. J., Andersson P., Blomgren A., Ryrfeldt A., Gerde P., Short inhalation exposures of the isolated and perfused rat lung to respirable dry particle aerosols; the detailed pharmacokinetics of budesonide, formoterol, and terbutaline Journal of Aerosol Medicine 2008 21 2 169 180
156. Tronde A., Nordn BO., Jeppsson A. B., Brunmark P., Nilsson E., Lennerns H., Bengtsson U. H., Drug absorption from the isolated perfused rat lungcorrelations with drug physicochemical properties and epithelial permeability Journal of Drug Targeting 2003 11 1 61 74 (Pubitemid 36527397)
157. Tronde A., Krondahl E., Von Euler-Chelpin H., Brunmark P., Bengtsson U. H., Ekstrm G., Lennerns H., High airway-to-blood transport of an opioid tetrapeptide in the isolated rat lung after aerosol delivery Peptides 2002 23 3 469 478 (Pubitemid 34143263)
158. Kroll F., Karlsson J. A., Nilsson E., Ryrfeldt A., Persson C. G. A., Rapid clearance of xanthines from airway and pulmonary tissues American Review of Respiratory Disease 1990 141 5 1167 1171 (Pubitemid 20172566)
159. Lahnstein K., Schmehl T., Rsch U., Rieger M., Seeger W., Gessler T., Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung International Journal of Pharmaceutics 2008 351 1-2 158 164 (Pubitemid 351186854)
160. Schermuly R. T., Schulz A., Ghofrani H. A., Breitenbach C. S., Weissmann N., Hildebrand M., Kurz J., Grimminger F., Seeger W., Comparison of pharmacokinetics and vasodilatory effect of nebulized and infused iloprost in experimental pulmonary hypertension: rapid tolerance development Journal of Aerosol Medicine 2006 19 3 353 363 (Pubitemid 44735391)
161. Beck-Broichsitter M., Gauss J., Gessler T., Seeger W., Kissel T., Schmehl T., Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles Journal of Aerosol Medicine 2010 23 1 47 57
162. Brazzell R. K., Smith R. B., Kostenbauder H. B., Isolated perfused rabbit lung as a model for intravascular and intrabronchial administration of bronchodilator drugs I: isoproterenol Journal of Pharmaceutical Sciences 1982 71 11 1268 1274 (Pubitemid 13230071)
163. Brazzell R. K., Kostenbauder H. B., Isolated perfused rabbit lung as a model for intravascular and intrabronchial administration of bronchodilator drugs II: isoproterenol prodrugs Journal of Pharmaceutical Sciences 1982 71 11 1274 1281 (Pubitemid 13230072)
164. Raabe O. G., Yeh H. S., Newton G. J., Phalen R. F., Velasquez D. J., Walton W. H., Deposition of inhaled monodispers aerosols in small rodents Inhaled Particles IV 1977 Oxford, UK Pergamon Press 3 21
165. Tronde A., Baran G., Eirefelt S., Lennerns H., Bengtsson U. H., Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung Journal of Aerosol Medicine 2002 15 3 283 296 (Pubitemid 34983134)
166. Hofstetter C., Flonder M., Thein E., Hoeg S., Kemming G. I., Kisch-Wedel H., Kreyling W. G., Zwissler B., Aerosol delivery during mechanical ventilation
167. MacLoughlin R. J., Higgins B. D., Laffey J. G., O'Brien T., Optimized aerosol delivery to a mechanically ventilated rodent Journal of Aerosol Medicine 2009 22 4 323 332
168. Niemeier R. W., Bingham E., An isolated perfused lung preparation for metabolic studies Life Sciences 1972 11 16 807 820
169. Kroll F., Karlsson J.-A., Nilsson E., Lung mechanics of the guinea-pig isolated perfused lung Acta Physiologica Scandinavica 1986 128 1 1 8 (Pubitemid 16023700)
170. Uhlig S., Heiny O., Measuring the weight of the isolated perfused rat lung during negative pressure ventilation Journal of Pharmacological and Toxicological Methods 1995 33 3 147 152
171. Uhlig S., Wollin L., An improved setup for the isolated perfused rat lung Journal of Pharmacological and Toxicological Methods 1994 31 2 85 94 (Pubitemid 24161762)
172. Liu X., Wang J. Y., Khlentzos A. M., Fontaine F., Nikolovski J., Goh L. A., Roberts M. S., Influence of perfusate composition on drug disposition in the in-situ perfused rat lung International Journal of Pharmaceutics 2009 382 1-2 192 197
173. Hamoir J., Nemmar A., Halloy D., Wirth D., Vincke G., Vanderplasschen A., Nemery B., Gustin P., Effect of polystyrene particles on lung microvascular permeability in isolated perfused rabbit lungs: role of size and surface properties Toxicology and Applied Pharmacology 2003 190 3 278 285 (Pubitemid 36937218)
174. Nemmar A., Hamoir J., Nemery B., Gustin P., Evaluation of particle translocation across the alveolo-capillary barrier in isolated perfused rabbit lung model Toxicology 2005 208 1 105 113 (Pubitemid 40143331)
175. Tronde A., Nordn BO., Marchner H., Wendel A. K., Lennerns H., Bengtsson U. H., Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs Journal of Pharmaceutical Sciences 2003 92 6 1216 1233 (Pubitemid 36676468)
176. Manford F., Tronde A., Jeppsson A. B., Patel N., Johansson F., Forbes B., Drug permeability in 16HBE14o- airway cell layers correlates with absorption from the isolated perfused rat lung European Journal of Pharmaceutical Sciences 2005 26 5 414 420 (Pubitemid 41551574)
177. Rytting E., Bur M., Cartier R., Bouyssou T., Wang X., Krger M., Lehr C. M., Kissel T., In vitro and in vivo performance of biocompatible negatively-charged salbutamol-loaded nanoparticles Journal of Controlled Release 2010 141 1 101 107